Evidence map›Paper›PMID 33146897›Full record

ArticleCancer2021

The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma.

Benjamin R Campbell, Zhishan Chen, Daniel L Faden, Nishant Agrawal, Ryan J Li, Glenn J Hanna, N Gopalakrishna Iyer, Arnoud Boot, Steven G Rozen, Andre L Vettore and 6 more

Open access · greenAbstract read
In one paragraph

Article in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 50 citations in OpenAlex.

  1. Lymphatic Vessel Density or Area Are Not Reliable Prognostic Factors in Oral Cancer.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2026
    Article
  2. Article
  3. Early-Onset Oral Squamous Cell Carcinoma: Emerging Biological Insights, Risk Factors and Clinical Implications.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Trends in Oral Tongue Cancer Incidence in the US.JAMA otolaryngology-- head & neck surgery · 2024
    Article
  15. MicroRNAs targetingMolecular biology research communications · 2024
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 4 countries.

Benjamin R CampbellDepartment of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.ORCID 0000-0003-1750-4603
Zhishan ChenDivision of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Daniel L FadenHead and Neck Surgical Oncology, Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, Massachusetts.ORCID 0000-0001-5284-7762
Nishant AgrawalSection of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, Illinois.
Ryan J LiDepartment of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon.
Glenn J HannaHarvard Medical School, Boston, Massachusetts.
N Gopalakrishna IyerDepartment of Head and Neck Surgery, National Cancer Centre Singapore, Singapore, Singapore.ORCID 0000-0002-8812-6219
Arnoud BootCenter for Computational Biology, Duke-NUS Medical School, Singapore, Singapore.
Steven G RozenCenter for Computational Biology, Duke-NUS Medical School, Singapore, Singapore.
Andre L VettoreDepartment of Biological Sciences, Federal University of São Paulo, São Paulo, Brazil.
Binay PandaSchool of Biotechnology, Jawaharlal Nehru University, New Delhi, India.ORCID 0000-0002-5136-2090
Neeraja M KrishnanSchool of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Curtis R PickeringDepartment of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0002-7942-728X
Jeffrey N MyersDepartment of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Xingyi GuoDivision of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Krystle A Lang KuhsDepartment of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Duke-NUS Medical School · SGJawaharlal Nehru University · INThe University of Texas MD Anderson Cancer Center · USVanderbilt University · USBroad Institute · USHarvard University · USNational Cancer Centre Singapore · SGOregon Health & Science University · USUniversidade Federal de São Paulo · BRUniversity of Chicago · USUniversity of Kentucky · USVanderbilt University Medical Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Human Papillomavirus-Specific Biomarkers for the Prediction of Oropharyngeal Cancer RecurrenceK07CA218247 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KUHS, KRYSTLE A. · 2018 to 2021
$594k
NCI NIH HHS K07 CA218247NIDCR NIH HHSNIH HHS P30 CA016672
6 · The paper itself

Abstract

backgroundThe incidence of oral tongue squamous cell carcinoma (OTSCC) is increasing among younger birth cohorts. The etiology of early-onset OTSCC (diagnosed before the age of 50 years) and cancer driver genes remain largely unknown.

methodsThe Sequencing Consortium of Oral Tongue Cancer was established through the pooling of somatic mutation data of oral tongue cancer specimens (n = 227 [107 early-onset cases]) from 7 studies and The Cancer Genome Atlas. Somatic mutations at microsatellite loci and Catalog of Somatic Mutations in Cancer mutation signatures were identified. Cancer driver genes were identified with the MutSigCV and WITER algorithms. Mutation comparisons between early- and typical-onset OTSCC were evaluated via linear regression with adjustments for patient-related factors.

resultsTwo novel driver genes (ATXN1 and CDC42EP1) and 5 previously reported driver genes (TP53, CDKN2A, CASP8, NOTCH1, and FAT1) were identified. Six recurrent mutations were identified, with 4 occurring in TP53. Early-onset OTSCC had significantly fewer nonsilent mutations even after adjustments for tobacco use. No associations of microsatellite locus mutations and mutation signatures with the age of OTSCC onset were observed.

conclusionsThis international, multicenter consortium is the largest study to characterize the somatic mutational landscape of OTSCC and the first to suggest differences by age of onset. This study validates multiple previously identified OTSCC driver genes and proposes 2 novel cancer driver genes. In analyses by age, early-onset OTSCC had a significantly smaller somatic mutational burden that was not explained by differences in tobacco use. LAY SUMMARY: This study identifies 7 specific areas in the human genetic code that could be responsible for promoting the development of tongue cancer. Tongue cancer in young patients (under the age of 50 years) has fewer overall changes to the genetic code in comparison with tongue cancer in older patients, but the authors do not think that this is due to differences in smoking rates between the 2 groups. The cause of increasing cases of tongue cancer in young patients remains unclear.

Indexed as

AdultAgedAged, 80 and overAge of OnsetFemaleHumansMaleMiddle AgedMutationOncogenesSmokingSquamous Cell Carcinoma of Head and NeckTobacco UseYoung Adultage of onsetNOTCH1oral tongue cancertobaccoTP53

Identifiers

PMID33146897
PMCPMC7891879
OpenAlexW3096064458

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.